Aileron Therapeutics, Inc. SC 13G and SC 13G/A reports

Location
12407 N. Mopac Expy., Suite 250 #390, Austin, TX
Fiscal year end
December 31
Data updated at
11/14/2024, 04:07 PM
Form type Sec Links Description Filing date Reporting date
SC 13G Report Mar 5, 2024
SC 13G/A Report AMENDMENT NO. 2 TO SCHEDULE 13G Feb 14, 2024
SC 13G/A Report Feb 5, 2024
SC 13G Report SC 13G Nov 13, 2023
SC 13G/A Report AMENDMENT NO. 1 TO THE SCHEDULE 13G Feb 14, 2023
SC 13G/A Report Feb 14, 2023
SC 13G/A Report Feb 14, 2022
SC 13G/A Report 13G AMENDED ANNUAL FILING (ALRN) Feb 10, 2021
SC 13G/A Report Feb 9, 2021
SC 13G Report THE SCHEDULE 13G Jan 19, 2021
SC 13G Report Jun 8, 2020
SC 13G/A Report Feb 14, 2020
SC 13G/A Report 13G AMENDED ANNUAL FILING (ALRN) Feb 3, 2020
SC 13G/A Report Nov 12, 2019
SC 13G/A Report 13G - AMENDED MONTHLY FILING - ALRN Nov 8, 2019
SC 13G Report Apr 26, 2019
SC 13G Report 13G INITIAL MONTHLY FILING - ALRN Apr 9, 2019
SC 13G Report Apr 8, 2019
SC 13G/A Report APPLE TREE PARTNERS II, LP - AILERON THERAPEUTICS - SCHEDULE 13G/A-1 (EXIT) Jul 10, 2018
SC 13G Report APPLE TREE PARTNERS II, LP - AILERON THERAPEUTICS - SCHEDULE 13G Feb 9, 2018